pros and cons of tirzepatide for weight loss Benefits semaglutide pros and cons Is

, L-

Cardiovascular and Metabolic Benefits : Semaglutide, as demonstrated in the SELECT trial, has established long-term cardiovascular benefits, with an average weight loss of 10.2% over four years, highlighting its role in cardiometabolic risk reduction

Tirzepatide is a dual receptor agonist that acts on GLP-1 and GIP to help curb appetite, slow gastric emptying and support insulin sensitivity

Time to first cardiovascular problem among study participants The difference between the two groups may not sound like much, but its a massive result, says Amit Khera, a cardiologist at UT Southwestern Medical Center in Dallas who was not part of the trial

95% CI 0.710.91

This also concerns comparisons between the efficacy of long-acting somatostatin therapies and the GH-receptor antagonist pegvisomant